- 1. (5-Benzoyl-1H-benzimidazol-2-yl)-carbamic Acid Methyl Ester
- [A synthetic benzimidazole derivate and anthelmintic agent. Mebendazole interferes with the reproduction and survival of helminths by inhibiting the formation of their cytoplasmic microtubules, thereby selectively and irreversibly blocking glucose uptake. This results in a depletion of glycogen stores and leads to reduced formation of ATP required for survival and reproduction of the helminth. This eventually causes the helminths death. ( NCI )] (UMLS (NCI) C0025023) =Organic Chemical; Pharmacologic Substance ;
=Anthelminthics;
benzimidazole =MEBENDAZOLE 100 MG | - 51. BEN NEO SOFT TIS ABDOMEN
- [ ] (UMLS (ICD9CM) C0153978) =Neoplastic Process
|
- 2. 06-Benzyl Guanine
- [A drug that may improve the response of cancer cells to chemotherapy. ( NCI )] (UMLS (NCI) C0083812) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 52. BEN NEO SOFT TIS PELVIS
- [ ] (UMLS (ICD9CM) C0153979) =Neoplastic Process
|
- 3. 1 benzazine
- [bicyclic aromatic ring structure with one ortho nitrogen. ( CSP )] (UMLS (CSP) C0034424) =Organic Chemical =2-Ring Heterocyclic Compound;
nitrogenous heterocyclic compound =chloroquine;
PRIMAQUINE;
quinolinate;
kynurenate;
cyanine;
Aminoquinolines;
Hydroxyquinolines;
MEFLOQUINE;
Nitroquinolines;
QUINIDINE;
(-)-Quinine;
Quinolones;
flosequinan;
SAQUINAVIR;
MONTELUKAST | - 53. BEN NEO SOFT TIS THORAX
- [ ] (UMLS (ICD9CM) C0153977) =Neoplastic Process
|
- 4. 1, 4-Benzenedicarboximidamide, N, N''-bis[4-[imino(methylamino)methyl]phenyl]-, tetrahydrochloride
- [One of 800 terephthalanilides synthesized and tested preclinically in the late 1950's and early 1960's. Chosen in the 1990's for further clinical investigation by the NCI's Project for the Review of Old Drugs because of its structure and activity spectrum. ( NCI )] (UMLS (NCI) C1510442) Amidino TIC;
Terephthalamidine, N, N''-bis[p-(methylamidino)phenyl]-, tetrahydrochloride =Organic Chemical; Pharmacologic Substance ;
| - 54. BEN NEO SOFT TISSUE ARM
- [ ] (UMLS (ICD9CM) C0153975) =Neoplastic Process
|
- 5. 1,2-Benz(a)anthracene
- [A crystalline, aromatic hydrocarbon consisting of four fused benzene rings, produced by incomplete combustion of organic matter. Benz(a)anthracene is primarily found in gasoline and diesel exhaust, tobacco and cigarette smoke, coal tar and coal tar pitch, coal combustion emissions, charcoal-broiled foods, amino acids, fatty acids and carbohydrate pyrolysis products, wood and soot smoke, and creosote, asphalt and mineral oils. This substance is used only for research purposes. Benz(a)anthracene is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0220794) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 55. BEN NEO SOFT TISSUE HEAD
- [ ] (UMLS (ICD9CM) C0153974) =Neoplastic Process
|
- 6. 1,2-Benzenedicarboxylic Acid, Bis(2-ethylhexyl)
- [listed as a plasticizer by USP and MeSH. ( CSP )] (UMLS (NCI) C0012197) =Organic Chemical; Pharmacologic Substance; Biomedical or Dental Material =phthalate;
| - 56. BEN NEO SOFT TISSUE LEG
- [ ] (UMLS (ICD9CM) C0153976) =Neoplastic Process
|
- 7. 1,2-Benzisoxazole-3-methanesulfonamide
- [A sulfonamide derivative with an anticonvulsant property. The exact mechanism of action remains to be elucidated. Zonisamide appears to block sodium and calcium channels, thereby stabilizing neuronal membranes and suppressing neuronal hypersynchronization. Although zonisamide shows affinity for the gamma-aminobutyric acid (GABA) /benzodiazepine receptor ionophore complex, it does not potentiate the synaptic activity of GABA. In addition, this agent also facilitates both dopaminergic and serotonergic neurotransmission. ( NCI )] (UMLS (NCI) C0078844) =Organic Chemical; Pharmacologic Substance =[CN400] ANTICONVULSANTS;
isoxazole =ZONISAMIDE 100 MG | - 57. BEN NEO SOFT TISSUE NEC
- [ ] (UMLS (ICD9CM) C0153981) =Neoplastic Process
|
- 8. 1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, Sulfate(2:1)(Salt)
- [The sulfate salt form of metaproterenol, a short-acting and selective sympathomimetic beta-receptor agonist with bronchodilator activity. Metaproterenol sulfate binds beta-2 adrenergic receptors in bronchial smooth muscle and stimulates intracellular adenyl cyclase, thereby increasing the production of cyclic adenosine monophosphate (cAMP). Increased cAMP levels cause relaxation of bronchial smooth muscle, improve mucocliary clearance and reduce inflammatory cell mediator release, especially from mast cells. ( NCI )] (UMLS (NCI) C0025573) =Organic Chemical; Pharmacologic Substance =METAPROTERENOL;
=METAPROTERENOL SULFATE 0.4 %;
METAPROTERENOL SULFATE 0.6 %;
METAPROTERENOL SULFATE 0.65 MG/ACTUAT;
METAPROTERENOL SULFATE 10 MG;
METAPROTERENOL SULFATE 10 MG/5ML;
METAPROTERENOL SULFATE 20 MG;
METAPROTERENOL SULFATE 5 %;
| - 58. BEN NEO SOFT TISSUE NOS
- [ ] (UMLS (ICD9CM) C0496876) =Neoplastic Process
|
- 9. 1,4 benzenediol
- [1,4-dihydroxybenzene. ( CSP )] (UMLS (CSP) C0020306) =Organic Chemical; Pharmacologic Substance ;
=Hydroquinones;
phenol;
[DE900] DERMATOLOGICALS, TOPICAL OTHER;
=HYDROQUINONE 2 %;
HYDROQUINONE 3.3 %;
HYDROQUINONE 4 %;
| - 59. BEN NEO SPINAL MENINGES
- (UMLS (ICD9CM) C0154035) =Neoplastic Process
|
- 10. 1,4-Benzenediamine, 2,6-Dichloro-N(sup 1)-(4,5-dihydro-1H-imidazol-2-yl), Monohydrochloride
- [The hydrochloride salt form of apraclonidine, a clonidine derivative with selective alpha-2-adrenergic agonistic property. When administered directly to teyes, apraclonidine hydrochloride enhances aqueous humor outflow and decreases aqueous production by vasoconstriction. It is used mostly in ophthalmic preparations for decreasing intraocular pressure. ( NCI )] (UMLS (NCI) C0304657) =Organic Chemical; Pharmacologic Substance ;
=4-aminoclonidine;
=APRACLONIDINE HYDROCHLORIDE 0.5 %;
APRACLONIDINE HYDROCHLORIDE 1 % | - 60. BEN NEOPL PINEAL GLAND
- [A benign growth of the cells that comprise the pineal gland. Despite benign histology, symptoms can be produced due to the location: increased intracranial pressure, endocrine abnormalities, cerebellar and/or brainstem compression. The latter can produce a constellation of symptoms known as Parinaud's syndrome. ( NCI )] (UMLS (ICD9CM) C0154043) =Neoplastic Process
|
- 11. 1,4-Benzenedicarboximidamide
- [A derivative of the phthalanilide compounds. Terephthalamidine belongs to a family of compounds which appear to reversibly bind to the minor groove of the DNA double helix but not intercalate DNA. This agent also has been suggested to form ionic complexes with many biological components in vitro, including nucleic acids, proteins and lipids. ( NCI )] (UMLS (NCI) C0076116) =Organic Chemical; Pharmacologic Substance
| - 61. Benadryl
- (UMLS (NCI) C0700899) =Organic Chemical; Pharmacologic Substance
|
- 12. 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-(2-(di-methylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-(2S-cis)-,(S)-hydoxybutanedioate(1:1)
- [A benzothiazepine derivative and a calcium channel blocker with vasodilator, antihypertensive and cardiovascular properties. Diltiazem maleate inhibits the influx of calcium ions of coronary and peripheral vascular smooth muscle. This leads to a dilation of peripheral and coronary blood vessels, and results in a reduction of myocardial oxygen requirement and in an increase in myocardial oxygen delivery. In addition, diltiazem maleate has a potent negative chronotropic effect with only a mild negative inotropic effect. This drug is used as an antiarrhythmic and an antianginal agent. ( NCI )] (UMLS (NCI) C0282138) =Organic Chemical; Pharmacologic Substance ;
| - 62. Benazepril
- [A dicarbocyl-containing peptide and angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, benazepril is metabolized to its active form benazeprilat. Benazeprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II resulting in vasodilation. Benazeprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow. ( NCI )] (UMLS (NCI) C0053091) =Organic Chemical; Pharmacologic Substance ;
=[CV800] ACE INHIBITORS;
benzazepine =Benazepril HCl |
- 13. 10,11-Benzofluoranthene
- [A yellowish, aromatic hydrocarbon consisting of five fused rings and formed by the incomplete combustion of organic matter. Benzo(j)fluoranthene is primarily found in certain foods, cigarette smoke, gasoline exhaust, coal tar, coal smoke, oil heat emissions, crude oils and used motor oils. This substance is used only for research purposes. Benzo(j)fluoranthene is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0053206) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 63. Benazepril HCl
- [Thy hydrochloride salt of a dicarbocyl-containing peptide and angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, benazepril hydrochloride is metabolized to its active form benazeprilat. Benazeprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II and results in vasodilation. Benazepril hydrochloride also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow. ( NCI )] (UMLS (NCI) C0770917) Benazepril Hydrochloride;
BENAZEPRIL HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =benazepril;
=BENAZEPRIL HYDROCHLORIDE 20 MG;
BENAZEPRIL HYDROCHLORIDE 40 MG;
BENAZEPRIL HYDROCHLORIDE 5 MG;
BENAZEPRIL HYDROCHLORIDE 10 MG |
- 14. 11,12-Benzo[k]fluoranthene
- [A pale yellow aromatic hydrocarbon consisting of five fused rings and is produced by the incomplete combustion of organic matter. Benzo(k)fluoranthene is primarily found in gasoline exhaust, cigarette smoke, coal tar, coal and oil combustion emissions, lubricating oils, used motor oils and crude oils. This substance is used only for research purposes. Benzo(k)fluoranthene is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0053207) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 64. Bence Jones Myeloma
- [A condition in which plasma cells secrete immunoglobulin light chains of only one type, kappa or lambda. Light chain deposition disease is often associated with multiple myeloma or lymphoproliferative disease, but as many as 50% of patients have no evidence of neoplastic plasma cell proliferation. Light chains excreted in the urine are known as Bence Jones protein. Amyloidosis and severe renal failure occur more frequently than in multiple myeloma. Also known as Bence Jones myeloma. L-chain disease, L-chain myeloma, and LCDD. —2004 ( NCI )] (UMLS (NCI) C0238239) =Disease or Syndrome
|
- 15. 2 benzazine
- [bicyclic aromatic ring structure with one meta nitrogen. ( CSP )] (UMLS (CSP) C0022248) =Organic Chemical =2-Ring Heterocyclic Compound;
nitrogenous heterocyclic compound =bicuculline;
debrisoquin;
PAPAVERINE;
NELFINAVIR;
Atracurium;
emetine;
PAPAVERINE;
4H-Pyrazino(2,1-a)isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-;
doxacurium;
mivacurium;
moexipril;
QUINAPRIL;
SAQUINAVIR;
NELFINAVIR | - 65. Bence Jones protein
- [Dimers of immunoglobulin light chains, normally produced by plasma cells. Bence Jones proteins are sufficiently small to be excreted by the kidney. It is a characteristic protein found in the urine of most patients with multiple myeloma. It can be used to help in diagnosis of the disease and to monitor the response to treatment. ( NCI )] (UMLS (CSP) C0004965) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
- 16. 2,1,3-Benzothiadiazol-4-amine, 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-, Monohydrochloride
- [The hydrochloride salt form of tizanidine, an imidazoline derivative structurally similar to clonidine and an adrenergic agonist with muscle relaxant property. Tizanidine stimulates alpha2-adrenergic receptors in the central nervous system, thereby inhibiting presynaptic release of norepinephrine and increasing the inhibitory effect on alpha motor neurons and motor reflexes. Tizanidine exerts some activity at the postsynaptic excitatory amino acid receptors and imidazoline receptors which may contribute to the overall reduction in facilitation of spinal motor neurons. Overall, tizanidine hydrochloride causes muscle relaxation, reduces spasticity and antinociceptive effects. ( NCI )] (UMLS (NCI) C0771735) 5-Chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole Hydrochloride;
Tizanidine Hydrochloride;
TIZANIDINE HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance =TIZANIDINE;
=TIZANIDINE HYDROCHLORIDE 4 MG;
TIZANIDINE HYDROCHLORIDE 2 MG | - 66. Benchmark
- [A standard by which something can be measured or judged. ( NCI )] (UMLS (NCI) C0525063) =Quantitative Concept ;
|
- 17. 2,3-Benzfluoranthene
- [A colorless, aromatic hydrocarbon consisting of five fused rings and formed by the incomplete burning of organic matter. Benzo(b)fluoranthene is primarily found in gasoline exhaust, tobacco and cigarette smoke, coal tar, soot, amino acids and fatty acid pyrolysis products. This substance is used only for research purposes. Benzo(b)fluoranthene is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0053199) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 67. bends
- [A condition occurring as a result of exposure to a rapid fall in ambient pressure. Gases, nitrogen in particular, come out of solution and form bubbles in body fluid and blood. These gas bubbles accumulate in joint spaces and the peripheral circulation impairing tissue oxygenation causing disorientation, severe pain, and potentially death. ( MSH )] (UMLS (CSP) C0011119) =Disease or Syndrome ;
=Barotrauma;
|
- 18. 2-Benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride
- [The hydrochloride salt of bendamustine, a novel alkylating agent of the nitrogen mustard family with antitumor activity. Bendamustine, chemically related to the alkylator chlorambucil, has three active moieties: an alkylating group, in common with the nitrogen mustard family; a benzimidazole ring, which may act as a purine analog; and a butyric acid side-chain. This agent undergoes extensive first-pass metabolism by cytochrome p450 enzymes in vivo. One of the hydroxy metabolites, beta-hydroxybendamustine, alkylates and crosslinks macromolecules, thereby resulting in DNA, RNA and protein synthesis inhibition, and subsequently inducing apoptosis. ( NCI )] (UMLS (NCI) C0772139) Bendamustin Hydrochloride;
Bendamustine Hydrochloride =Organic Chemical; Pharmacologic Substance ;
| - 68. Bendylate
- (UMLS (NCI) C0700902) =Organic Chemical; Pharmacologic Substance
|
- 19. 2-benzofurancarboximide,N-(2-((1-(chloromethyl)-1,6-dihydro-8-methyl-5-(((phenylamino)carbonyl0oxy0benzo(1,2-b:4,3-b')dipyrrol-3(2H0-yl)carbonyl-1H-indol-5-yl)-6-(diethylamino)-,(S)
- [An anticancer drug that belongs to the family of drugs called alkylating agents. ( NCI )] (UMLS (NCI) C0172048) =Organic Chemical; Pharmacologic Substance ;
| - 69. beneficiary
- [Target on behalf of whom the service happens, but that is not necessarily present in the service. Can occur together with direct target to indicate that a target is both, as in the case where the patient is the indirect beneficiary of a service rendered to a family member, e.g. counseling or given home care instructions. This concept includes a participant, such as a covered party, who derives benefits from a service act covered by a coverage act. Note that the semantic role of the intended recipient who benefits from the happening denoted by the verb in the clause. Thus, a patient who has no coverage under a policy or program may be a beneficiary of a health service while not being the beneficiary of coverage for that service. ( HL7V3.0 )] (UMLS (HL7) C1550502) =Idea or Concept =indirect target;
|
- 20. 3,4-Benzpyrene
- [A crystalline, aromatic hydrocarbon consisting of five fused benzene rings and formed during the incomplete combustion of organic matter. 3,4-Benzpyrene is primarily found in gasoline and diesel exhaust, cigarette smoke, coal tar and coal tar pitch, charcoal-broiled foods and certain other foods, amino acids, fatty acids and carbohydrate pyrolysis products, soot smoke, creosote oil, petroleum asphalt and shale oils. This substance is used only for research purposes. 3,4-Benzpyrene is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0005052) =Organic Chemical; Hazardous or Poisonous Substance
| - 70. BeneFin (Lane Shark Cartilage Powder)
- (UMLS (NCI) C1135152) =Organic Chemical; Pharmacologic Substance ;
|
- 21. 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-Indol-2-one Monohydrochloride
- [The hydrochloride salt form of ziprasidone, a benzothiazolylpiperazine derivative and an atypical antipsychotic agent with an antischizophrenic property. Ziprasidone hydrochloride functions as an antagonist at the dopamine D2 and serotonin 5-HT2A and 5-HT1D receptors, and as an agonist at the 5-HT1A receptor. Ziprasidone hydrochloride also inhibits synaptic reuptake of serotonin and norepinephrine. The mechanism of action by which ziprasidone hydrochloride exerts its antischizophrenic effect is unknown but is potentially mediated through a combination of dopamine D2 and serotonin 5-HT2 antagonism. This agent also has antagonistic activity against histamine H1 and alpha-1-adrenergic receptors. ( NCI )] (UMLS (NCI) C0380392) =Organic Chemical; Pharmacologic Substance ;
| - 71. Benefit
- [The positive effects of something. ( NCI )] (UMLS (NCI) C0814225) Benefits =Quantitative Concept
|
- 22. 6,7 benzomorphan
- [ ] (UMLS (CSP) C0178433) =Organic Chemical ;
=morphinan;
=cyclazocine;
PENTAZOCINE | - 72. Beneflur
- (UMLS (NCI) C0700805) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 23. BEN
- [A country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo. (NCI) ( NCI )] (UMLS (NCI) C0005005) =Geographic Area ;
| - 73. Benemid
- (UMLS (NCI) C0591159) =Organic Chemical; Pharmacologic Substance
|
- 24. BEN HY HT/KD I-IV W/O HF
- [ ] (UMLS (ICD9CM) C0155608) =Disease or Syndrome
| - 74. Benicar
- (UMLS (NCI) C1122245) =Organic Chemical; Pharmacologic Substance ;
|
- 25. BEN HY HT/KD ST V W/O HF
- [ ] (UMLS (ICD9CM) C0155610) =Disease or Syndrome
| - 75. benign
- [(beh-NINE) Not cancerous; does not invade nearby tissue or spread to other parts of the body. ( NCI )] (UMLS (NCI) C0205183) =Qualitative Concept
|
- 26. BEN HY KID W CR KID I-IV
- [ ] (UMLS (ICD9CM) C0155596) =Disease or Syndrome
| - 76. Benign Accessory Sinus Neoplasm
- (UMLS (NCI) C0347222) =Neoplastic Process
|
- 27. BEN HYP HT/KD I-IV W HF
- [ ] (UMLS (ICD9CM) C0155609) =Disease or Syndrome
| - 77. Benign Acquired Melanosis
- (UMLS (NCI) C1334256) Intraepithelial Melanocytic Hyperplasia;
=Pathologic Function |
- 28. BEN HYP HT/KD STG V W HF
- [ ] (UMLS (ICD9CM) C0155611) =Disease or Syndrome
| - 78. Benign Adenomyoepithelioma of Breast
- (UMLS (NCI) C1332477) Benign Adenomyoepithelioma of the Breast;
Benign Breast Adenomyoepithelioma;
=Neoplastic Process |
- 29. BEN HYP KID W CR KID V
- [ ] (UMLS (ICD9CM) C0155598) =Disease or Syndrome
| - 79. Benign Adipose Tissue Neoplasm
- [A benign tumor composed of adipose (fatty) tissue. The most common representative of this category is the lipoma. ( NCI )] (UMLS (NCI) C0346118) =Neoplastic Process
|
- 30. BEN NEO BONES ANKLE/FOOT
- [ ] (UMLS (ICD9CM) C0153967) =Neoplastic Process
| - 80. Benign Adrenal Cortex Neoplasm
- [A non-metastasizing neoplasm arising from the adrenal cortex. (NCI05) ( NCI )] (UMLS (NCI) C1368669) Benign Adrenal Cortex Tumor =Neoplastic Process
|
- 31. BEN NEO BONES WRIST/HAND
- [ ] (UMLS (ICD9CM) C0153964) =Neoplastic Process
| - 81. Benign Adrenal Gland Neoplasm
- [A non-metastasizing neoplasm arising from the adrenal gland. (NCI05) ( NCI )] (UMLS (NCI) C0154040) =Neoplastic Process
|
- 32. BEN NEO CEREBR MENINGES
- (UMLS (ICD9CM) C0154033) =Neoplastic Process
| - 82. Benign Adrenal Medulla Neoplasm
- [A non-metastasizing neoplasm arising from the adrenal medulla. (NCI05) ( NCI )] (UMLS (NCI) C0686512) =Neoplastic Process
|
- 33. BEN NEO FALLOPIAN TUBE
- [ ] (UMLS (ICD9CM) C0496889) =Neoplastic Process
| - 83. Benign Adult Brain Neoplasm
- (UMLS (NCI) C1332466) Benign Adult Brain Tumor;
Benign Neoplasm of Adult Brain;
Benign Neoplasm of the Adult Brain;
Benign Tumor of Adult Brain;
Benign Tumor of the Adult Brain;
Brain Neoplasms, Adult, Benign;
=Neoplastic Process ;
|
- 34. BEN NEO FEM GENITAL NEC
- (UMLS (ICD9CM) C0154004) =Neoplastic Process
| - 84. Benign Ameloblastoma
- (UMLS (NCI) C1332470) =Neoplastic Process
|
- 35. BEN NEO FEM GENITAL NOS
- (UMLS (ICD9CM) C0154005) =Neoplastic Process
| - 85. Benign Anal Granular Cell Neoplasm
- [A non-metastasizing neoplasm arising from the anus. It is characterized by the presence of large polygonal cells with abundant granular cytoplasm. ( NCI )] (UMLS (NCI) C1332471) Benign Anal Granular Cell Tumor;
Benign Anal Myoblastoma;
Benign Granular Cell Neoplasm of Anus;
Benign Granular Cell Neoplasm of the Anus;
Benign Granular Cell Tumor of Anus;
Benign Granular Cell Tumor of the Anus;
Benign Myoblastoma of Anus;
Benign Myoblastoma of the Anus;
=Neoplastic Process |
- 36. BEN NEO ISLETS LANGERHAN
- [ ] (UMLS (ICD9CM) C0496872) =Neoplastic Process
| - 86. Benign Anal Neoplasm
- [A non-metastasizing neoplasm arising from the anus. ( NCI )] (UMLS (NCI) C0347276) =Neoplastic Process
|
- 37. BEN NEO LACRIMAL DUCT
- [Abnormal growth of the cells of the lacrimal duct without malignant characteristics. ( NCI )] (UMLS (ICD9CM) C0154029) =Neoplastic Process
| - 87. Benign Anterior Tongue Neoplasm
- (UMLS (NCI) C1332472) Benign Anterior Tongue Tumor;
Benign Neoplasm of Anterior Tongue;
Benign Neoplasm of the Anterior Tongue;
Benign Tumor of Anterior Tongue;
Benign Tumor of the Anterior Tongue =Neoplastic Process |
- 38. BEN NEO LACRIMAL GLAND
- [Abnormal growth of the cells of the lacrimal gland without malignant characteristics. ( NCI )] (UMLS (ICD9CM) C0154024) =Neoplastic Process
| - 88. Benign Apocrine Neoplasm
- (UMLS (NCI) C1332473) Benign Apocrine Neoplasm of Skin;
Benign Apocrine Neoplasm of the Skin;
Benign Apocrine Skin Neoplasm;
Benign Apocrine Skin Tumor;
Benign Apocrine Tumor;
Benign Apocrine Tumor of Skin;
Benign Apocrine Tumor of the Skin =Neoplastic Process |
- 39. BEN NEO LIVER/BILE DUCTS
- [ ] (UMLS (ICD9CM) C0347277) =Neoplastic Process
| - 89. Benign Appendix Neoplasm
- [A non-metastasizing neoplasm arising from the appendix. ( NCI )] (UMLS (NCI) C0496860) =Neoplastic Process
|
- 40. BEN NEO LONG BONES ARM
- [ ] (UMLS (ICD9CM) C0153963) =Neoplastic Process
| - 90. Benign Atrial Neoplasm
- (UMLS (NCI) C1332474) Benign Atrial Tumor;
Benign Neoplasm of Atrium of Heart;
Benign Neoplasm of Cardiac Atrium;
Benign Neoplasm of the Atrium of the Heart;
Benign Neoplasm of the Cardiac Atrium;
Benign Tumor of Atrium of Heart;
Benign Tumor of Cardiac Atrium;
Benign Tumor of the Atrium of the Heart;
Benign Tumor of the Cardiac Atrium =Neoplastic Process |
- 41. BEN NEO LONG BONES LEG
- [ ] (UMLS (ICD9CM) C0153966) =Neoplastic Process
| - 91. Benign Axillary Neoplasm
- (UMLS (NCI) C0684828) =Neoplastic Process
|
- 42. BEN NEO LOWER JAW BONE
- (UMLS (ICD9CM) C0004994) =Neoplastic Process ;
| - 92. Benign Bartholin's Gland Neoplasm
- (UMLS (NCI) C0347500) =Neoplastic Process
|
- 43. BEN NEO MAJOR SALIVARY
- [ ] (UMLS (ICD9CM) C0496858) =Neoplastic Process
| - 93. Benign Basal Cell Neoplasm
- (UMLS (NCI) C0474802) =Neoplastic Process ;
|
- 44. BEN NEO MALE GENITAL NEC
- (UMLS (ICD9CM) C0154012) =Neoplastic Process
| - 94. Benign Base of the Tongue Neoplasm
- (UMLS (NCI) C0345612) =Neoplastic Process
|
- 45. BEN NEO NASAL CAV/SINUS
- (UMLS (ICD9CM) C0153951) =Neoplastic Process
| - 95. Benign Bladder Neoplasm
- [A benign abnormal growth of the cells that comprise the bladder. ( NCI )] (UMLS (NCI) C0154017) =Neoplastic Process
|
- 46. BEN NEO PARAGANGLIA NEC
- (UMLS (ICD9CM) C0154045) =Neoplastic Process
| - 96. Benign Blood Vessel Neoplasm
- [A benign neoplasm arising from arteries or veins. ( NCI )] (UMLS (NCI) C0685121) =Neoplastic Process
|
- 47. BEN NEO PERITONEUM
- [ ] (UMLS (ICD9CM) C0347406) =Neoplastic Process
| - 97. Benign Bone Giant Cell Tumor
- [A benign, locally aggressive bone tumor, usually arising in the end of long bones or the vertebrae. The tumor is composed of round or oval mononuclear cells and uniformly distributed osteoclast-like giant cells. Clinical presentation includes pain, edema, and decrease range of motion in the affected joint. ( NCI )] (UMLS (NCI) C0855006) Benign Giant Cell Tumor of Bone;
=Neoplastic Process |
- 48. BEN NEO RIBS/STERN/CLAV
- [ ] (UMLS (ICD9CM) C0153962) =Neoplastic Process
| - 98. Benign Bone Neoplasm
- (UMLS (NCI) C0684516) =Neoplastic Process
|
- 49. BEN NEO SCALP/SKIN NECK
- [ ] (UMLS (ICD9CM) C0153986) =Neoplastic Process
| - 99. Benign Bone Neurilemmoma
- (UMLS (NCI) C1332476) Benign Bone Schwannoma;
Benign Neurilemmoma of Bone;
Benign Neurilemmoma of the Bone;
Benign Schwannoma of Bone;
Benign Schwannoma of the Bone =Neoplastic Process |
- 50. BEN NEO SKULL/FACE BONE
- [ ] (UMLS (ICD9CM) C0153960) =Neoplastic Process
| - 100. Benign Brain Neoplasm
- [Primary neoplasms of the brain which are noninvasive and tend to grow slowly. They are generally classified by location and histologic type. In children, astrocytomas of the cerebellum represent relatively common benign brain neoplasms. In adult meningiomas, neurilemomas and pituitary tumors comprise the majority of benign tumors. ( NCI )] (UMLS (NCI) C0496899) =Neoplastic Process
|
home
